Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$837,360
+$688,977 QoQ
Shares Held
80,593
+483.3% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#104
of 334 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 25%
Shared 24%
None 51%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $67,490,391 across 30 Drug Manufacturers - Specialty & Generic names. PRGO ranks #12 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
123,778 | $20,861,543 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,210 | $10,950,383 | |
| 3 | ZTS |
Zoetis Inc.
|
90,284 | $6,487,806 | |
| 4 | VTRS |
Viatris Inc
|
280,668 | $4,457,007 | |
| 5 | HLN |
Haleon plc
|
443,467 | $4,137,546 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
106,508 | $3,608,490 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
184,772 | $2,677,345 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
40,488 | $2,589,207 |
All Filings in PRGO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $837,360 | 80,593 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $148,383 | 13,816 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $261,250 | 9,960 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $239,414 | 9,323 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $233,440 | 6,876 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $270,782 | 7,549 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $219,744 | 6,446 | Shares | Sole | 2023-02-15 | |
| 2022-06-30 | $247,679 | 6,105 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||